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Abstract
Background: Cytoplasmic polyadenylation element binding proteins (Cpebs) are a family of proteins that bind to defined groups of 
mRNAs and regulate their translation. While Cpebs were originally identified as important features of oocyte maturation, recent interest 
is due to their prospective roles in neural system plasticity.
Results: In this study we made use of bioinformatic tools and methods including NCBI Blast, UCSC Blat, and Invitrogen Vector NTI 
to comprehensively analyze all known isoforms of four mouse Cpeb paralogs extracted from the national UniGene, UniProt, and NCBI 
protein databases. We identified multiple alternative splicing variants for each Cpeb. Regions of commonality and distinctiveness were 
evident when comparing Cpeb2, 3, and 4. In addition, we performed cross-ortholog comparisons among multiple species. The exon 
patterns were generally conserved across vertebrates. Mouse and human isoforms were compared in greater detail as they are the most 
represented in the current databases. The homologous and distinct regions are strictly conserved in mouse Cpeb and human CPEB pro-
teins. Novel variants were proposed based on cross-ortholog comparisons and validated using biological methods. The functions of the 
alternatively spliced regions were predicted using the Eukaryotic Linear Motif resource.
Conclusions: Together, the large number of transcripts and proteins indicate the presence of a hitherto unappreciated complexity in the 
regulation and functions of Cpebs. The evolutionary retention of variable regions as described here is most likely an indication of their 
functional significance.
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Introduction
Cytoplasmic polyadenylation element binding   proteins 
are  a  family  of  mRNA  binding  proteins  that  play 
essential regulatory roles in the translation of defined 
mRNAs. First discovered during oocyte maturation,1 
the  role  of  Cpeb-mediated  control  of  translation 
has now been expanded to include a wider   variety 
of    scenarios  including  cell  cycling2,3  and    synaptic 
  plasticity.4  The  identification  of  Cpebs  in  a  wide 
  variety of tissues5,6 indicates that they may function 
as a ubiquitous means for controlling the translation 
of specifically targeted mRNAs.
Four Cpeb paralogs have been identified in mouse. 
The first family member, Cpeb1, was identified using 
single-step RNA affinity chromatography. Enriched 
in oocyte, it is indispensible for cytoplasmic poly(A) 
elongation during oocyte maturation.1 Transcripts for 
Cpeb2 were first identified in mouse testis using an 
EST database and degenerative PCR.1,7 Cpeb3 and 
Cpeb4 were first detected in mouse brain via PCR 
and Northern blotting using primers/probes similar 
to human CPEB-like sequences.5 The N termini of 
Cpeb1–4 are highly variable, whereas the C-termini, 
where RNA recognition motifs (RRMs) reside, are 
more conservative. Sequence analysis has revealed 
that  Cpeb1  is  distant  from  Cpeb2,  3  and  4  in  the 
  family tree.5 Expression of Cpeb1, 2, 3 and 4 mRNAs 
in  the  hippocampus  demonstrated  overlapping,  yet 
distinct patterns.8 Cpeb3, in particular, has been asso-
ciated with human memory.9 The cytoplasmic poly-
adenylation element (CPE), a short U-rich motif, has 
been identified in the 3’UTRs of mRNAs targeted by 
Cpeb1,10,11 while a distinct loop-forming U-rich motif 
appears to be indispensible for the binding of Cpeb4 
and Cpeb3, but not of Cpeb1 protein.8
Previous biological findings suggested that Cpeb 
paralogs, although distinct in their own ways, may 
share some commonality in their structure and dis-
tribution, and may possibly provide some compensa-
tion and redundancy in their function. A systematic 
analysis of Cpebs based on the current databases and 
literature would surely be informative and instruc-
tive to ongoing Cpeb-related research. The purpose 
of the current study is to perform a comprehensive 
survey and analyses on three scales: within each par-
alog,  across-paralog,  and  across-ortholog. Through 
data  mining  of  the  current  nucleotide  and  protein 
databases and previous publications, we derived the 
alternative  splicing  patterns  for  each  Cpeb.  Some 
of the newly proposed alternatively spliced regions 
were  confirmed  experimentally.  Cross-paralog  and 
cross-ortholog comparisons illuminated the similari-
ties and the unique attributes of four Cpebs, as well 
as the extraordinarily high level of conservation of 
each Cpeb across species. A bioinformatics analysis 
revealed the presence of specific functional motifs.
Results and Discussion
cpeb1 protein isoforms with internal 
deletions of 1 or 5-amino acid (aa),  
or with an n-terminal truncation of 75-aa
A total of nine cDNA sequences for mouse Cpeb1 were 
extracted from the UniGene database (supplementary 
Table  1).  Fragmented  sequences  and  redundant 
sequences  were  identified  with  the  bioinformatics 
tools Blast and Vector NTI and removed from further 
analysis. Four non-redundant full-length cDNAs were 
aligned to mouse genomic DNA (derived from the 
UCSC mouse genome) to infer exon-exon boundar-
ies and to derive alternatively spliced exons (Fig. 1A). 
The comparison demonstrated that the variances in the 
lengths of the first and last exons lead to   different 5’ 
UTRs or 3’ UTRs, respectively (Fig. 1A). Two vari-
able sequences in the protein coding region (CDS), 
including a 3-nucleotide (nt) deletion resulting from 
partial exon 4 skipping and a 15-nt deletion resulting 
from partial exon 7 skipping, would lead to altered 
proteins. The presence of transcripts with or without 
the 15-nt variable region has been confirmed in mouse 
brain, ovary,12 and retina (Fig. 1B left).
Two  Cpeb1  protein  sequences  were  extracted 
from  the  UniProt  protein  database  and  aligned 
using    Vector  NTI  software  (Fig.  1C).  Meanwhile, 
we  computationally  translated  all  non-redundant 
full-length  Cpeb1  transcripts  with  the  aid  of  Vec-
tor  NTI,  and  then  compared  the  translated  protein 
products  to  the  protein  sequences  in  the  database. 
Our computational translation of cDNA BC144948.1 
yielded a protein with a 5-aa deletion, which is not 
documented in the protein database (Fig. 1C). The 
removal of the 5-aa motif is due to partial skipping 
of exon 7 (15-nt) as previously described (Fig. 1A). 
In addition to the evidence at the transcript level in 
the  mouse  (Fig.  1B  left),  two  isoforms  of  human 
CPEB1   proteins with the same 5-aa deletion13 were Bioinformatics analysis of Cpeb1–4
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identified in the UniProt database (Fig. 1D). Strin-
gent   homology is evident between mouse and human 
as we later conclude. In particular, the locations and 
sequences of the 5-aa deletion in mouse Cpeb1 and 
human CPEB1 are identical (Fig. 1C, 1D, Fig. 6D). 
Additional  evidence  includes  the  presence  of  the 
90-nt and 105-nt variants of a particular exon, which 
corresponds  to  exon  7  in  mouse  (supplementary 
Table 2, the asterisk), across vertebrates. The strin-
gent conservation of exon patterns across vertebrates 
strongly  supports  the  presence  of  the  15-nt  (5-aa) 
alternative splices within this exon which likely will 
have important functional implications.
The 15-nt (5-aa) is located within the first RRM 
(Fig. 1C). Further analysis identified that the 5-aa is 
adjacent to the octamer consensus of the first RRM 
(Fig. 5, green box). The insertion or deletion of the 
5-aa  may  have  a  pivotal  impact  on  the  specificity 
of  Cpeb1,  because  the  sequences  surrounding  the 
consensus of RRMs are important for the specificity 
of RNA binding.14,15 To what extent this 5-aa impacts 
RNA binding is yet to be established.
Two  alternative  splicing  isoforms  containing  a 
75-aa N-terminal truncation were evident in human 
CPEB1  (Fig.  1D). With  the  knowledge  that  there 
is  a  near-identical  conservation  between  human 
Figure 1. Analysis of Cpeb1. A) Transcripts of mouse Cpeb1. Only non-redundant full-length Unigene sequences were used for this analysis, with their 
accession numbers listed on the right. ATg and sTOP indicate the presence of translational initiation and termination sites, respectively. The different 
lengths of the first and last exons likely represent the presence of variable 5’ and 3’ UTRs, respectively. The alternative splices of the first 3-nt of exon 4 and 
the last 15-nt of exon 7 (highlighted in grey) would generate different protein products. A novel isoform with deletion of exon 2 (also highlighted in grey) is 
predicted based on published sequences of the human protein. The deletion of exon 2 leads to the use of an alternative translational start codon in exon 3. 
B) Expression of Cpeb1 transcripts in adult mouse retina. The locations of the primers for rT-Pcr are aligned to the diagram of Cpeb1 genomic DnA, 
in which boxes represent exons and double lines represent introns. Photographs of DNA gels demonstrate the expression of multiple Cpeb1 transcripts 
in the retina including those with and without the 15-nt of exon 7 (left), and without exon 2 (right). The identity of each band was confirmed by nucleotide 
sequencing. c) Isoforms of mouse Cpeb1 proteins. Two isoforms were extracted from the UniProt database (Q059Z2, P70166). The computational trans-
lation of cDNA BC144948.1 yields a third isoform. A fourth isoform is predicted based on two human CPEB1 homologs (Q9BZB8-2, Q9BZB8-4). RNA 
recognition motifs (RRMs) are indicated with grey boxes. Triangles represent phosphorylation sites experimentally confirmed (solid)21 or predicted (open) 
based on cross-ortholog comparisons. A 1-aa deletion, a 5-aa deletion, and a 75-aa N-terminal truncation are each indicated with dashed line boxes. The 
locations of functional motifs are shown as numbered amino acid sites at the top of the diagram, and those of the alternative spliced regions at the bottom, 
as might be seen in the longest isoform. D) Isoforms of human CPEB1 proteins. Four isoforms are extracted from the UniProt database. The RRMs, the 
phosphorylation sites, and the 5-aa deletion are all present in human cPeB1 at the same locations as seen in mouse. Two isoforms have 75-aa n terminal 
truncations (Q9BZB8-2, Q9BZB8-4). This led to our predication of the existence of a similar isoform in mouse. Human CPEB1 has an additional 4-aa at 
the c-terminus than mouse cpeb1 (shown to the right of the dashed line). numeric annotations refer to the longest isoform.
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CPEB1 and mouse Cpeb1 (Fig. 6B–D), the question 
arises: Does the 75-aa truncation in human have a 
  counterpart  in  mouse?  Based  on  our  theoretical 
translation with Vector NTI, we postulated that the 
75-aa truncation in mouse could be derived from the 
removal of exon 2, which leads to a frame shift and 
an alternative translational initiation site (Fig. 1A). 
Therefore, we designed primers spanning this alter-
native region in mouse. A primer pair at exon 1/3 
junction and within exon 3 confirmed the presence of 
a Cpeb1 transcript “exon 2 deletion” in mouse retina 
(Fig.  1B  right).  This  PCR-based  evidence  at  the 
level of transcripts   provided support for the presence 
of this novel isoform of mouse Cpeb1 with 75-aa   
N-terminal truncation.
cpeb2 protein isoforms with internal 
deletions of 30-aa or 8-aa
We extracted eight cDNA sequences for Cpeb2 from 
the UniGene database (supplementary Table 3). Three 
non-redundant, full-length sequences were used for 
further analysis (Fig. 2A). A recently updated sequence 
for one isoform (NM_175937.3) was also included in 
the diagram. The alignment demonstrated that the vari-
ances in the lengths of the first and last exons of Cpeb2 
lead to different 5’ UTRs and 3’ UTRs, respectively. 
The partial skipping of exon 2 removes 3-nt from the 
5’ UTR. The alternative splices of exon 4 and exon 
7 remove 90-nt and 24-nt respectively from the coding 
region. Our RT-PCR results confirmed the expression 
of transcripts with or without the 90-nt variable region 
in adult mouse retina (Fig. 2B).   Transcripts without 
the 24-nt was not detected, perhaps due to competition 
for the same primers which can lead to masking of the 
less abundant isoforms by the more dominant ones, as 
observed in Cpeb3.6 Alternatively, this could be due to 
a distinct tissue specificity and/or condition. The alter-
native use of these two regions was also observed in 
a number of other vertebrate species   (supplementary 
Table 4, the asterisks).
One  mouse  Cpeb2  protein  sequence  was 
documented in the UniProt database (Q812E0). An 
additional isoform which was recently updated in the 
NCBI protein database (but not in the UniProt database) 
was added to the top (Fig. 2C, NP_787951.2). Both 
sequences  contain  an  8-aa  deletion  resulting  from 
the removal of exon 7 (Fig. 2A). When we translated 
non-redundant  full-length  Cpeb2  transcripts  using 
Vector  NTI,  we  identified  a  novel  protein  from   
the  translation  of  cDNA  AK0421065.1  (Fig.  2C). 
This predicted   isoform has a 30-aa deletion resulting 
from the removal of exon 4 (90-nt), which has been 
confirmed  at  the  level  of  transcripts  (Fig.  2B).  In 
addition,  we  identified  the  same  30-aa  deletion  in 
human CPEB2 (Fig. 2D). Six human CPEB2 protein 
isoforms,  including  the  one  recently  deposited  in 
the NCBI protein database (NP_001170853.1), are 
distinguished  by  the  presence  or  absence  of  three 
motifs of 22-aa, 30-aa, or 8-aa each (Fig. 2D). The 
sequences  and  the  relative  locations  of  the  30-aa 
and 8-aa in human CPEB2 are comparable to those 
in mouse. The strong homology between mouse and 
human (Fig. 6B–D) and the similar findings in human 
provided  additional  support  for  the  presence  of  a 
mouse Cpeb2 isoform with a 30-aa deletion.
Both  mouse  and  human  Cpeb2  sequences  have 
been  updated  in  the  NCBI  database  during  the 
preparation of this manuscript. Of particular interest, 
the updated sequences demonstrate the presence of 
an extra-long isoform of Cpeb2—almost double the 
previously published size (Fig. 2C, 2D, top isoforms). 
Our  sequence  alignment  demonstrated  that  both 
the  previous  and  the  updated  mouse  isoforms  are 
  legitimate—the use of an extended exon1 leads to the 
much longer N terminus in the newly uncovered iso-
form (Fig. 2A, insert). This may be of relevance to 
prior investigations of CPEB3, in which antibodies 
recognized the predicted protein at ~78 kD in western 
blots, but also detected an additional protein band 
above 100 kD6,8 (see below).
cpeb3 protein isoforms with internal 
deletions of 23-aa or 8-aa, an n-terminal 
truncation of 216-aa, or a c-terminal 
truncation of 132-aa with an altered  
c terminus
Eight full-length cDNA sequences of mouse Cpeb3 
were extracted from the UniGene database (supple-
mentary Table 5). In addition, partial sequences of two 
transcripts were experimentally identified (Fig. 3A, 
sequences with dashed lines).5,6 Sequence alignments 
indicated that the alternative usage of exons 1–3 and 
variable length of exon 13 lead to different 5’ UTRs Bioinformatics analysis of Cpeb1–4
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or 3’ UTRs, respectively (Fig. 3A). Five alternative 
splices  within  the  CDS  region  involve  intra-exon 
skipping  of  exon  4  (388-nt),  partial  skipping  of 
exon 5 (69-nt), deletion of exon 7 (24-nt), deletion 
of exon 11 (115-nt), and extension of exon 11. The 
intra-exon skipping of exon 4 results in the use of an 
alternative translation start codon. The extension of 
exon 11 leads to altered downstream sequence and an 
early termination. The majority of these alternatively 
spliced regions have been experimentally identified 
in many tissues, including in multiple regions of the 
central nervous system.6 The partial skipping of exon 
5 and the deletion of exon 7 have been observed in 
some other vertebrates (supplementary Table 6, the 
asterisks).
Six  protein  sequences  of  mouse  Cpeb3  were 
extracted  from  the  UniProt  and  the  NCBI  protein 
databases. Sequence comparisons demonstrated four 
variable regions (Fig. 3C). The alternative usage of a 
23-aa region and an 8-aa region is attributable to the 
alternative splicing in exon 5 and exon 7,   respectively. 
A 216-aa N-terminal truncation may result from the 
use  of  an  alternative  translation  initiation  codon 
when intra-exon skipping occurs to exon 4. A 132-aa 
C-terminal truncation which removes the majority of 
the second RRM2, and terminates with four distinct 
amino  acids  (Fig.  3C,  Q7TN99-5)  can  be  derived 
from the extension of exon 11 (Fig. 3A).
The sequences and locations of the 23-aa and the 
8-aa  regions  are  conserved  in  human  CPEB3  and 
Figure 2. Analysis of Cpeb2. A) Transcripts of mouse Cpeb2. Three previously established non-redundant full-length Unigene sequences and a newly 
updated sequence (the top one) are used for the analysis, with their accession numbers listed on the right of the figure. ATG and STOP indicate the 
presence of translational initiation and termination sites, respectively. The different lengths of the first and the last exons likely represent the presence of 
variable 5’ UTR and 3’ UTR, respectively. The alternative splice of the first 3-nt of exon 2 also result in a different 5’ UTR. The alternative splices of exon 4 
(90-nt) or exon 7 (24-nt) would generate different protein products. Insert: the previous version and the new version of nM_175937 sequences are both 
legitimate. In the new version, the first exon was extended towards both ends and “fused” with exon 2. This would lead to a much longer cDNA and a longer 
n terminus in the protein. B) Expression of Cpeb2 transcripts in adult mouse retina. The locations of the primers for rT-Pcr are aligned to the diagram 
of Cpeb2 genomic DNA, in which boxes represent exons and double lines represent introns. The photograph of DNA Gel demonstrates the expression of 
two Cpeb2 transcripts in the retina with and without exon4. The identity of each band was confirmed with nucleotide sequencing. c) Isoforms of mouse 
Cpeb2 proteins. The previously established isoform (Q812E0; NP_787951.1) has an 8-aa deletion. The newly updated isoform (NP_787951.2) has an 
8-aa deletion as well as a much longer N-terminus, which is due to the use of a longer exon 1 in cDNA NM_175937.3. The computational translation of 
cDNA AK042065.1 generates an additional isoform which has a 30-aa deletion. RRMs are indicated with gray boxes. Triangles represent phosphorylation 
sites experimentally confirmed.22 A 30-aa deletion and an 8-aa deletion are indicated in dashed line boxes. The locations of functional motifs are shown as 
numbered amino acid sites at the top of the diagram, and those of the alternative spliced regions at the bottom, as might be seen in a conceptual isoform 
without any deletion. D) Isoforms of human CPEB2 proteins. Five isoforms are extracted from the UniProt database. The RRMs, the phosphorylation sites 
(open triangles, predicted based on cross-ortholog comparisons), and the two deletions are all present in human cPeB2 at similar locations. The recently 
updated, unusually long isoform of human CPEB2 (NP_001170853.1) was aligned to its closest isoform. The first 68-aa in the previously established 
human CPEB2 isoforms was thought to be a region that was unique for human, but now aligns to a region in the extra-long isoform of mouse Cpeb2.
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mouse Cpeb3 (Fig. 3C, 3D). One human isoform has 
a deletion of 17-aa, which includes the 8-aa and the 
adjacent 9-aa C-terminal to it (Fig. 3D, Q8NE35-1). 
To further explore the validity of the 17-aa   deletion, 
we  compared  additional  organisms. A  particular 
exon (supplementary Table 6, column denoted by the 
pound sign) shows two variants (141-nt or 168-nt) 
among the species investigated. We postulated that 
the presence of the 141-nt was due to a 27-nt skipping 
within the 168-nt exon. Sequence alignment indicated 
that this 168-nt is exon 8 in mouse Cpeb3 (Fig. 3A), 
and the 27-nt skipping would occur in the beginning 
of exon 8 (Fig. 3A, the part of exon 8 highlighted 
in gray), and would lead to a deletion in the protein 
product of 9-aa next to the aforementioned 8-aa. The 
removal of the 8-aa disrupts a Pkb recognition site, 
Figure 3. Analysis of Cpeb3. A) Transcripts of mouse Cpeb3. eight non-redundant full-length Unigene sequences were used for the analysis, with the 
accession numbers listed on the right. ATg and sTOP indicate the presence of translational initiation and termination sites, respectively. Partial sequences 
of two transcripts were derived from previous publications.5,6 The different lengths of the first and the last exons likely represent different 5’ UTR and 3’ 
UTR, respectively. The alternative splices of exon 2 and 3 would also result in different 5’ UTRs. The intra-exon skipping of exon 4 (388-nt), the partial skip-
ping of exon 5 (69-nt), and the deletion of exon 7 (24-nt) or exon 11 (115-nt) would generate different protein products. Exon 11 extension (AK161513.1) 
would lead to an early translational termination and an altered 4-aa at the c-terminus. Four additional alternatively splice variants, all with a 27-nt skipping 
at the beginning of exon 8, were identified in this study. Insert: The comparison between two cDNAs that use different 5’ UTRs. The upstream elongation 
of exon 1 in AK044639.1, with additional alternative splice(s), may lead to the use of an alternative translation start codon, which would generate an extra-
long isoform of Cpeb3 protein with an extended N-terminus. B) Expression of Cpeb3 transcripts in adult mouse retina. The locations of the primers for 
rT-Pcr are aligned to the diagram of Cpeb3 genomic DNA, in which boxes represent exons and double lines represent introns. Photographs of DNA gel 
demonstrate the expression of four Cpeb3 transcripts in the retina without the 27-nt in exon 8, and with or without the 24-nt (exon 7) and the 69-nt (exon 
5). The identity of each band was confirmed with nucleotide sequencing. Many of the other alternatively spliced regions have been confirmed in previous 
publications5,6 in great details. Tissue abbreviation: rtn—retina, hipp—hippocampus, ctx—cortex, cere—cerebellum, s.c.—spinal cord, o.b.—olfactory 
bulb, thy—thymus, kid—kidney. c) Isoforms of mouse Cpeb3 proteins. Six isoforms are extracted from the UniProt database. RRMs were indicated with 
gray boxes. Triangles represent phosphorylation sites experimentally confirmed21,24,25 (solid) or predicted (open) according to cross-paralog comparisons, 
respectively. A 216-aa n-terminal truncation, two internal deletions of 23-aa motif and 8-aa motif, and a 132-aa c terminal truncation with altered c termi-
nus were indicated in dashed lines. The C-terminal truncation (Q7TN99-5) removes the majority of the second RRM and alters the last four amino acids 
from VeLA to geWK. The locations of functional motifs are shown as numbered amino acid sites at the top of the diagram, and those of the alternative 
spliced regions at the bottom, as might be seen in the longest isoform. D) Isoforms of human CPEB3 proteins. Three isoforms are extracted from Uni-
Prot and ncBI databases. The rrMs, the phosphorylation sites, and the 23-aa and 8-aa deletions are all present in human cPeB3 at similar locations. 
numeric annotations refer to a conceptual isoform without any deletion.
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whereas the deletion of the 17-aa abolishes the Pkb 
phosphorylation site as well as a Pka phosphorylation 
site (Table 2). The 27-nt deletion has been detected in 
mouse testis and to a lesser degree in the hippocam-
pus, cortex, and olfactory bulb (Fig. 3B).
One human CPEB3 isoform (BAG54433.1) has a 
317-aa N-terminal truncation (Fig. 3D). The strong 
homology between mouse and human prompted us 
to question the validities of the 317-aa truncation in 
the human and the 216-aa truncation in the mouse 
(Fig.  3C). The  216-aa  truncation  in  mouse  Cpeb3 
is  derived  from  an  intra-exon  skipping  of  exon  4 
(Fig. 3A). The corresponding cDNA (AK127060.1) 
for human CPEB3 isoform with 317-aa truncation 
has a very short 5’ UTR. Computational   translation 
  indicated that the truncation of 317-aa could be due to 
an incomplete 5’ sequence of the cDNA. Based on the 
stringent  conservation  between  mouse  and  human, 
particularly  in  the  alternatively  spliced  regions 
(Fig. 6 C–D), it is possible that this human CPEB3 
protein isoform has an N terminal truncation of 216-
aa  instead  of  317-aa. Techniques  such  as  5’  rapid 
amplification of cDNA ends (5’ RACE) may be used 
in future studies to obtain the complete 5’ sequence 
of this transcript as a means to confirm the length of 
N-terminal truncation in human CPEB3.
More drastic changes appear in the Cpeb3 isoform 
with a 132-aa C-terminal truncation and an altered tail 
(VELA→GEWK) (Fig. 3C, and yellow box in Fig. 5). 
This isoform lacks the majority of the second RRM, 
including its octamer consensus. This is likely to have 
a significant impact on RNA-protein interaction and 
specificity. The DNA or RNA binding proteins thus 
far identified have one to four RRMs.16 NMR charac-
terization of the structures of several proteins revealed 
different binding mechanisms for even- and odd-num-
bered  RRMs.  For  example,  heterogeneous  nuclear 
ribonucleoprotein A1 (Hnrnpa1) and polypyrimidine 
tract binding protein (Ptbb), which contain two and 
four  RRMs,  respectively,  form  homodimers  when 
binding to two molecules of mRNA in anti-parallel 
arrangement.17,18 In contrast, poly (A) binding protein 
2 (Pabp2) which has a single RRM, forms homodimers 
in the absence of RNA, but becomes monomeric upon 
mRNA  binding.19  Thus  the  Cpeb3  isoform  with  a 
132-aa C-terminal truncation and an altered tail would 
likely have its binding   characteristics altered.
The  largest  predicted  size  for  mouse  Cpeb3  is 
approximately  78  kD,  but  a  protein  greater  than 
100  kD  has  also  been  detected  with  antibodies  in 
western  blots.6,8  This  larger  protein  has  been  pro-
posed to be a pre-protein.6 Since Cpeb2 and Cpeb3 
are closely-  related in the Cpeb family (Fig. 6A), the 
recent finding of the extra-long Cpeb2 (Fig. 2A, C, D, 
the top isoforms) makes it plausible to postulate the 
presence of a similar extra-long isoform for Cpeb3. 
Both human and chimpanzee have a beginning exon 
of 193-nt (supplementary Table 6, the double pound 
signs) which, if mapped to mouse genome, would be 
adjacent to the 61-nt exon. In addition, one isoform 
of mouse Cpeb3 indeed has an extended “5’ UTR” 
(Fig. 3A, AK044639.1). A putative translation indi-
cates that an upstream extension of the 61-nt exon 
into and beyond the 193-nt would lead to a continuous 
extension of Cpeb3 protein beyond the N-  terminus. 
We analyzed a genomic sequence of about 2000-bp 
upstream of the first exon, and realized that for the 
extended translation to be long enough (that is, to 
match the difference between ~100 kD and 78 kD), 
additional  upstream  splice(s)  may  be  necessary 
(Fig. 3, insert). Additional experimental evidence is 
required to determine the validity and the exact length 
of an extra-long Cpeb3.
cpeb4 protein isoforms with internal 
deletions of 17-aa or 8-aa, or an 
n-terminal truncation of 382-aa
Sixteen cDNA sequences representing mouse Cpeb4 
were extracted from the UniGene database (supple-
mentary  Table  7).  After  removing  the  fragmented 
and redundant sequences, we used three remaining 
cDNA sequences for sequence alignment. Two addi-
tional isoforms based on a previous report were also 
used  for  analysis5 ( Fig.  4A).  The  comparison  of 
these five sequences demonstrated that variations in 
exon 1 could lead to different 5’ UTRs or alternative 
translation  initiation  sites.  Variations  in  the  length 
of  the  last  exon  could  lead  to  different  3’  UTRs. 
Alternative splicing of exon 3 and exon 4 would likely 
result in the removal of 51-nt and 24-nt, respectively 
(Fig. 4A). All four isoforms related to altered exons 
3 and 4 have been identified in mouse brain tissue.5 
Two isoforms in the same region are also evident in 
adult mouse retina (Fig. 4B). The alternative use of Wang and cooper
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these two exons in Cpeb4 is highly conserved among 
vertebrates (supplementary Table 8, the asterisks).
Four  isoforms  of  mouse  Cpeb4  proteins  were 
extracted from the UniProt database. The alignment of 
the protein isoforms reflects the deletions of 17-aa and 
8-aa motifs (Fig. 4C), which correspond to the removal 
of exon 3 and exon 4, respectively (Fig. 4A). Com-
putational translation of cDNA BC079599.1 yielded 
a novel protein with a 382-aa N-terminal truncation 
(Fig. 4C). The deletion of 382-aa, like the deletions of 
the 17-aa, and 8-aa, was identified in human CPEB4 
at the same locations (Fig. 4D). These sequences of 
the  alternatively  spliced  regions  were  also  strictly 
  conserved in mouse and human (Fig. 6D).
Across-paralog comparison of mouse 
cpeb1, 2, 3 and 4
The overall sequence of Cpeb1 has been reported to 
have low homology to Cpeb2–4.5 We demonstrate 
here that the alternatively spliced regions of Cpeb1 
are rather different from those of Cpeb2–4 (Fig. 5, 
6C–D). This fact strengthens the previously reported 
notion that Cpeb1 is a distant cousin of Cpeb2–4. 
Cpeb2,  3,  and  4  have  almost  identical  RRMs  but 
variable N termini. Of interest, an 8-aa motif within 
the variable region is stringently conserved among 
Cpeb2–4.  This  motif  is  located  N-terminal  to  the 
first RRM (Fig. 5, the red box). Its deletion leads to 
the removal of certain functional motifs for protein 
Figure 4. Analysis of Cpeb4. A) Transcripts of mouse Cpeb4. Three non-redundant full-length Unigene sequences were used for this analysis, with the 
accession numbers listed on the right. ATg and sTOP indicate the presence of translational initiation and termination sites, respectively. Partial sequences 
of two transcripts are derived from a previous publication.5 The different lengths of the first and the last exons likely represent the presence of different 5’ 
UTR and 3’ UTR, respectively. The alternative splices of exon 3 (51-nt) or exon 4 (24-nt) would generate different protein products. A shorter first exon 
leads to an alternative translational initiation site in Bc079599.1. B) Expression of Cpeb4 transcripts in the adult mouse retina. The locations of the primers 
for rT-Pcr are aligned to the diagram of Cpeb4 genomic DNA, in which boxes represent exons and double lines represent introns. The photograph of 
DNA Gel demonstrates the expression of multiple Cpeb4 transcripts in the retina with and without the exon 3. The identity of each band was confirmed by 
nucleotide sequencing. c) Isoforms of mouse Cpeb4 proteins. Four isoforms were extracted from the UniProt database. The computational translation of 
cDNA BC079599.1 would generate an additional isoform. RRMs are indicated with gray boxes. Triangles represent phosphorylation sites experimentally 
confirmed (solid)21,23 or predicted (open) based on cross-paralog comparisons, respectively. A 17-aa deletion, an 8-aa deletion, and a 382-aa n-terminal 
truncation are each indicated with dashed line boxes. The locations of functional motifs are shown as numbered amino acid sites at the top, and those of 
the alternative spliced regions at the bottom, as might be seen in the longest isoform. D) Isoforms of human CPEB4 proteins. Three isoforms are extracted 
from the UniProt database. The rrMs, the phosphorylation sites, the deletions and the truncation are all present in human cPeB4 at the same locations. 
All numerical locations refer to the longest isoform.
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Cpeb1 GSDHLSDLISSLRISPPLPFLSMTGNGPRDPLKMGVGSR-------------------MDQEQAALAAVAPSPTSAPKRWPGASVWPSWDLLG-------2 66
Cpeb2 RTDNNSNTLLPLQVRSSLQLPAWGSDSLQDSWCTAAGTSRIDQDRSRMYDSLNMHSLENSLIDIMRAEHDPLKGRLSYPHPGTDNLLMLN(ARSYGRRR)GR 222
Cpeb3 RTDN-GNNLLPFQDRS-RPYDTFNLHSLENSLMDMIRTD-HEPLKGKHYPPS---GPPMSFADIMWRNHFAGRMGINFHHPGTDNIMALNTRSYGRRRGR 418
Cpeb4 RADN----IFPFPERP----RTFDMHSLES-----------------------------SLIDIMRAENDSIKGRLNYSYPGSDSSLLINARTYGRRRGQ 429
:*:: .: .: .. .. :. **:. :
8-aa 30-aa      23-aa         17-aa
Cpeb1 APKDPFSIEREARLHRQAAAVNEATCTWSGQLPPRNYKNPIYSCKVFLGGVPWDITEAGLVNTFRVFGSLSVEWPGKDGKHPRCPPKGNMPKGYVYLVFE3 66
Cpeb2 SSLFPIDDSLLDDGHSDQVGVLNSPTCYS--AHQNGERIERFSRKVFVGGLPPDIDEDEITASFRRFGPLVVDWPHKAESKSYFPPK G -----Y AFLLFQ3 15
Cpeb3 SSLFPFEDAFLDDSHGDQA-LSSGLSSPT--RCQNGERVERYSRKVFVGGLPPDIDEDEITASFRRFGPLVVDWPHKAESKSYFPPK G -----Y AFLLFQ5 10
Cpeb4 SSLFPMEDGFLDDGRGDQP-LHSGLGSPHCFTHQNGERVERYSRKVFVGGLPPDIDEDEITASFRRFGPLIVDWPHKAESKSYFPPK G -----Y AFLLFQ5 23
:. *:.: :: .. .. :: ** **:**:** ** :. :*** *.* *:*** .:. **  ***.:*:*:
Cpeb1 LEKSVRALLQACSHDPLSPDGLSEYYFKMSSRRMRCKEVQVIPWVLADSNFVWSPSQRLDPSRTVFVGALHGMLNAEALAAILNDLFGGVVYAGIDTD-K 465
Cpeb2 EESSVQALIDACIEE------DGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDPRKTIFVGGVPRPLRAVELAMIMDRLYGGVCYAGIDTDPE 409
Cpeb3 EESSVQALIDACLEE------DGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDPRKTIFVGGVPRPLRAVELAMIMDRLYGGVCYAGIDTDPE 604
Cpeb4 DESSVQALIDACIEE------DGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDPRKTIFVGGVPRPLRAVELAMIMDRLYGGVCYAGIDTDPE6 17
*.**:**::** .: .: *: :**: :***:* ** :**:** .* ** ** :*:***.: *.* ** *::* :*** *******:
Cpeb1 HKYPIGSGRVTFNNQRSYLKAVTAAFVEIKTTKFTKKVQIDPY-LEDSLCLICS-----SQPGPFFCRDQVCFKYFCRSCWHWRHSMEGLRHHSPLMRNQ5 59
Cpeb  2 LKYPKGAGRVAFSNQQSYIAAISARFVQLQHGDIDKRVEVKPYVLDDQMCDECQGARCGGKFAPFFCANVTCLQYYCEFCWANIHSRAGREFHKPLVKEG5 09
Cpeb3 LKYPKGAGRVAFSNQQSYIAAISARFVQLQHNDIDKRVEVKPYVLDDQMCDECQGTRCGGKFAPFFCANVTCLQYYCEYCWASIHSRAGREFHKPLVKEG7 04
Cpeb4 LKYPKGAGRVAFSNQQSYIAAISARFVQLQHGEIDKRVEVKPYVLDDQLCDECQGARCGGKFAPFFCANVTCLQYYCEYCWAAIHSRAGREFHKPLVKEG7 17
*** *:***:*.**:**:* ::** *::: .: *:*::.** *:*.:* *. .: .****:. *::*:*. ** ** * ..*.**:::
Cpeb1 KN---------- 561
Cpeb2 ADRPRQIHFRWN 521
Cpeb3 GDRPRHVPFRWS 716
Cpeb  4 GDRPRHISFRWN 729
:
hexamer                                                                           octamer
consensus                   consensus
hexamer
consensus
octamer
consensus
RRM2
NSLM
-- -SLI
.: :
RRM1
Figure 5. comparison of the conserved regions in mouse cpeb1–4 protein. The alternatively spliced 17~30-aa regions are highlighted in blue, the 
alternatively spliced 8-aa in red, and the alternatively spliced 9-aa in orange. The parentheses indicate that all cpeb2 isoforms recorded in the UniProt 
database have the 8-aa deleted. cpeb2, 3, and 4 share high homology in the 8-aa and the 9-aa regions, but little homology in the 17~30-aa region. The 
underlined sequences represent the first and second RRMs, respectively, in all four CPEBs. The regions in grey are hexamer and octamer consensus 
sequences within the RRMs. The hexamer and octamer consensus sequences within the RRMs and the linker between two RRMs are identical in Cpeb2–4, 
suggesting that it is highly likely that cpeb2–4 share the same protein/rnA interaction mechanisms. The sequences surrounding the consensuses, 
N terminal to the first RRM, and C terminal to the second RRM are similar among Cpeb2–4, with a few amino acid replacements. This suggests that 
Cpeb2–4 recognizes similar substrates. In contrast, Cpeb1 demonstrates significant differences to Cpeb2–4 within these regions, including the consensus 
sequences, suggesting that cpeb1 not only employs a distinct mechanism for protein/rnA interaction, but also targets a different group of rnAs. The 
insertion of the 5-aa in Cpeb1 (highlighted in green) is adjacent to the octamer consensus in the first RRM, possibly posing a potential impact on its speci-
ficity. An early termination with an altered tail which alters VELA (highlighted in yellow) to GEWK disrupts the second RRM in a Cpeb3 isoform. This may 
pose an impact on both the binding mechanism and the substrate specificity of Cpeb3. Accession numbers used for the alignment are as follows: Cpeb1: 
NP_031781, Cpeb2: NP_787951; Cpeb3: NP_938042; Cpeb4: NP_080528. Alignment was achieved with the aid of ClustalW2. Asterisks represent per-
fect matches; colons represent substitutions with similar amino acids; periods represent substitutions with rather distinct amino acids.
cleavage, protein-protein interaction, and phosphory-
lation (Table 1–3). Although the deletion of the 8-aa 
disrupts a Pkb recognition site, the newly identified 
9-aa deletion adjacent to the 8-aa in Cpeb3 (Fig. 5, 
orange box) would lead to the removal of this Pkb 
phosphorylation site and a Pka phosphorylation site 
altogether (Table 2). Based on the sequence homology 
among Cpeb2–4, it is plausible to predict that the 9-aa 
may be alternatively spliced in Cpeb2 and Cpeb4 as 
well. The deletion of the 9-aa would likely cause the 
removal of a Pka phosphorylation site in Cpeb2 as 
well (Table 1). However, this Pka phosphorylation 
site is absent from Cpeb4 due to a single amino acid 
substitution (GRSSLLP -. GQSSLLP, Fig. 5).
Another common feature of Cpeb2–4 is the alterna-
tively splicing of the 17~30-aa N-terminal to the 8-aa 
motif. In contrast to the 8-aa and 9-aa sequences which 
are highly conserved among Cpeb2–4, the 17~30-aa 
sequences show little evidence of homology among 
the three paralogs (Fig. 5, the blue boxes). Functional 
predictions  demonstrated  that  the  deletion  of  this 
region removes motifs implicated in protein-protein 
interactions, phosphorylation, and post-  translational 
modifications (Table 1–3). Noteworthy among these 
findings is the deletion of the 23-aa motif in Cpeb3: 
this  not  only  removes  certain  functional  motifs, 
but  also  creates  a  novel  site  for  Mapk  interaction 
(Table 2).
This  17~30-aa  variable  regions  become  shorter 
and closer to the 8-aa motif in the order of Cpeb2→ 
Cpeb3→Cpeb4, until the gap closes in Cpeb4 (Fig. 5). 
Functional predictions revealed that the linker regions Wang and cooper
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may harbor class III PDZ (postsynaptic density-95, 
discs-large,  zonula  occludens-1)  domain  binding 
motifs. The numbers of such motifs vary: there are 
3 in CPEB2 (Table 1), 1 in Cpeb3 (Table 3), and none 
in Cpeb4 (Table 5). The sequences of class III PDZ 
domain binding motifs are also different. Such motifs 
may recruit different Cpeb paralogs to different pro-
tein partners, thereby leading to distinctive localiza-
tions and functions.
Together, the aforementioned variations enclosing 
the 8-aa, 9-aa, and 17~30-aa region would likely deter-
mine protein-protein interaction, phosphorylation, and 
post-translational modifications of Cpebs. The func-
tional significance of this region is of great interest 
for future studies.
Three paralogs, Cpeb1,  3  and 4,  have isoforms 
with large N-terminal truncations. Such truncations 
may  have  a  major  impact  on  the  function  of  the 
proteins. For instance, the Cpeb4 isoform with a large 
N terminal truncation may be deprived of many, if not 
all, of the phosphorylation sites (Fig. 4C). This would 
likely make it a putative candidate for a dominant 
negative form. Our analysis using the bioinformatics 
tool Eukaryotic Linear Motif resource (ELM, http://
elm.eu.org) indicated that the N-terminal fragments 
may also harbor featured sites such as those required 
for post-translational modification and protein-protein 
interaction (data not shown). The presence or absence 
of such sites may alter signaling pathways, stimulus-
dependence, or the development of particular protein 
complexes.
The C termini of RNA binding proteins determine 
the affinity and specificity of RNA binding. Two highly 
conserved short consensus motifs, a hexamer and an 
octamer, are separated by about 30-aa and embedded 
in a structurally conserved, but not sequence conserved 
RRM region of approximately 90-aa16,20 (Fig. 5). These 
two short consensuses are deemed hallmarks of RNA 
binding proteins. The linker sequences between two 
RRMs are also highly conserved among RNA bind-
ing proteins. The hexamer and octamer consensuses 
and the linker regions are essential for protein-RNA 
interaction. However, the specificity of RNA binding 
is determined by sequences surrounding the hexamer 
and octamer, as well as sequences N terminal to the 
first RRM and C terminal to the second RRM.14,15 
Based on the near-identical homology of these impor-
tant functional regions in Cpeb2, 3, and 4 (Fig. 5), 
Cpeb1
CPEB1
Cpeb2
CPEB2
Cpeb3
CPEB3
Cpeb4
CPEB4
  Cpeb2- ARSYGRRR (GRSSLFPIDD)
  Cpeb3- TRSYGRRR(GRSSLFPFED)
  Cpeb4- ARTYGRRR (GQSSLFPMED)
Cpeb2- (NNSNTLLPLQ) VRSSLQLPAWGSDSLQDSWCTAAGTSRIDQ
Cpeb3- (IRTDHEPLKG) GKHYPPSGPPMSFADIMWRNHFA
Cpeb4- (IMRAENDSIK) GRLNYSYPGSDSSLLIN
Cpeb2- DRSRMYDSLNMHSLENSLIDIMRAEHDPLKGRLSYPHPGTDNLLMLN
Cpeb3- GRMGINFHHPGTDNIMALN
Cpeb4- none
17~30-aa
region
Linker
8-aa region
A absent in human
S to T in human
G to S in human
1-aa            Cpeb1- A
5-aa           Cpeb1- (DGKHPRCPPK) GNMPK (GYVYLVFELEK)
A
B
C
D
Orthologs Homology Comments
mouseC peb1 vs.h uman CPEB1 95%
Both canonical forms.
Excludea ne xtra 4-aa at humanC -terminus.
mouseC peb2 vs.h uman CPEB2 99%
Both with 8-aa deletion.
Excludea ne xtra 68-aaa t human N-terminus.
mouseC peb3 vs.h uman CPEB3 96%B othw ith8 -aad eletion.
mouseC peb4v s. humanC PEB4 98% Both canonicalf orms.
                            5 aa
30 aa 8 aa
VELA
23 aa  8 aa 
17 aa  8 aa
Figure 6. comparisons between (MOUse) cpebs and (hUMAn) cPeBs. 
A) The nM_sequences from multiple species (complete sequences) are 
used for the generation of a phylogenetic tree. The tree demonstrated 
that the distances between orthologs are significantly closer than those 
between paralogs. B) Percentage homology between mouse and human 
for  each  cPeB  protein.  refseq  (nM_)  sequences  are  used  for  the 
comparison. Certain regions in human proteins are excluded from the 
estimate of percentage homology as indicated in the comments. c) The 
patterns and locations of deletions have little or no difference in mouse 
and human. In Cpeb1, the 5-aa alternative splice occurs within the first 
rrM. In cpeb2–4, the 8-aa deletion is always located n-terminal to the 
rrMs, and the 17~30-aa deletion n-terminal to the 8-aa sequence. The 
17~30-aa sequence becomes shorter and closer to the 8-aa in the order 
of cpeb2→cpeb3→ cpeb4, until the gap closes in cpeb4. The same is 
true  for  human  cPeBs.  D)  sequence  comparisons  of  the  variable 
regions between mouse Cpebs and human CPEBs. The majority of the 
alternatively spliced sequences and the adjacent sequences (indicated 
in parentheses) are identical in mouse and human, with only a few single 
nucleotide substitutions (in red).Bioinformatics analysis of Cpeb1–4
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we predict that Cpeb2, 3, and 4 recognize similar 
targets. However, Cpeb1, whose sequence deviates 
significantly from that of Cpeb2–4 even with regard 
to the short consensus, must recognize a different set 
of targets and employ a distinct mechanism for RNA 
interaction.  Indeed  certain  RNA  oligonucleotides 
interact with Cpeb3 and Cpeb4, but not Cpeb1 pro-
tein, and the reverse is also true.8
Across-ortholog comparisons provide 
new insights
Comparisons  across  species  can  be  instructive.  In 
this study we found that the exon structures of Cpeb 
orthologs  among  vertebrates  are  almost  identical. 
Most of the internal exons are of exactly the same 
lengths  across  a  wide  range  of  organisms  from 
zebrafish to human (supplementary tables 2, 4, 6, 8). 
With  regard  to  the  proteins,  the  phylogenetic  tree 
clearly   demonstrated that they are better conserved 
across species than across paralogs (Fig. 6A). Of all 
currently documented Cpeb proteins, the orthologs are 
closer to each other than the paralogs are. It is also evi-
dent that Cpeb protein paralogs are highly conserved 
between mouse and human. Despite an additional 4-aa 
C-terminal “tag” in human CPEB1 (Fig. 1D), the rest 
of the sequences between mouse and human orthologs 
are nearly identical (Fig. 6B). The patterns, locations, 
and sequences of the   alternatively spliced regions are 
strictly preserved between mouse and human (Fig. 6C, 
6D). For instance, the 5-aa deletion in mouse Cpeb1, 
although not present in mouse Cpeb2–4, is found to 
be identical in human CPEB1. This variation is also 
evident at the level of the transcripts in multiple spe-
cies  (supplementary Table  2).  Similar  findings  are 
true in the alternative spliced regions in Cpeb2–4, as 
demonstrated for multiple vertebrates at the level of 
the transcripts (supplementary tables 4, 6, 8), with 
little or no variation between mouse and human at the 
level of the proteins (Fig. 6D). These findings pro-
vide strong foundations for cross-species predictions. 
For example, novel isoforms in one species may be 
predicted based on the evidence in another, as dem-
onstrated by the discovery of the “exon 2 deletion” 
transcript of mouse Cpeb1 (Fig. 1A, 1C, 1D), and 
the partial skipping of exon 8 in mouse Cpeb3 (sup-
plementary Table 6, Figure 3A, 3D). Information in 
one species may also be borrowed to cross-examine 
the accuracy in another, as in the question regarding 
the length of N-terminal truncation of human CPEB3. 
Evidently, such comparative analysis may be used to 
discover unknown isoforms or to establish the correct 
sequences for known isoforms.
One may also exploit such logic to predict func-
tional motifs in one species according to the other. 
A good example is the prediction of phosphoryla-
tion sites (PhophoSitePlus). A few amino acids have 
been confirmed as phosphorylation sites in mouse or 
human (Figs. 1–4C, D, the solid triangles) by vari-
ous techniques including nuclear magnetic resonance 
(NMR) and mass spectrometry (MS).21,25 Based on 
the stringent homology between mouse and human, 
the same amino acids at identical or similar locations 
were identified and predicted to be phosphorylation 
sites in the other species (Figs. 1–4C, D, the open 
triangles).31
Multiple levels of variability indicate 
extraordinary complexity in the  
regulation and function of Cpebs
The presence of more than one isoform in each Cpeb 
reveals the complexity in their regulatory capabilities 
and functions. Each alternative splicing may confer 
an additional layer of divergence in the regulation 
of biological and cellular functions. Variances in the 
UTRs, in particular, may attest to regulations at the 
transcriptional  level,  that  is,  alternative  transcrip-
tion initiation or termination. Variations in the UTRs 
then impose additional controls over translation, spe-
cifically, the initiation, termination, and efficiency of 
translation. Another layer of regulation, alternative 
splicing, leads to variances in the protein sequences 
themselves. The differences in protein sequences dic-
tate the uniqueness of their functions. Alterations of 
as small as a few amino acids (for example, the 5-aa 
insertion in Cpeb1, the 8-aa and the 9-aa deletions 
in Cpeb3) may alter the when, where and how the 
Cpebs perform their functions and connect with their 
targets.
conclusions
In  conclusion,  our  study  delineated  alternative 
  splicing isoforms for mouse Cpeb1–4. New isoforms 
were predicted based on theoretical translation, cross-
ortholog  comparison,  and  experimental  validation. 
Functions of the alternatively spliced regions were pre-
dicted using bioinformatics approaches. The   variety Wang and cooper
74  Bioinformatics and Biology Insights 2010:4
of transcript structures and protein structures indicate 
an  extraordinary  complexity  in  the  regulation  and 
  functions of the Cpebs.
Methods
Animal handling and tissue collection
All animal experimental procedures were performed 
in compliance with animal care regulations set by the 
University  of  Louisville  Institutional Animal  Care 
and Use Committee (IACUC) as well as the Asso-
ciation for Research in Vision and Ophthalmology 
(ARVO) statement for the use of animals in vision 
research.
C57/BL6 mice (Charles River Laboratories, Davis, 
CA)  were  used  in  this  study  to  confirm  the  pres-
ence and/or absence of some isoforms predicted by 
in silico methods. The animals were euthanized with 
CO2 followed by cervical dislocation. Retinas were 
dissected immediately and frozen on dry ice before 
proceeding to RNA extraction.
RNA extracton and RT-PCR
Frozen retinas were homogenized using a PowerGen 
250 homogenizer (Fisher Scientific, Pittsburgh, PA). 
Total  RNA  was  extracted  using  RNeasy  mini  kits 
(Qiagen, Valencia, CA) following the manufacturer’s 
instructions. The concentration of RNA was deter-
mined using a BioPhotometer (Eppendorf, Westbury, 
NY), and the quality of RNA was determined by the 
ratio of 28S/18S on an agarose gel. RNA was frozen 
in −80 °C for long term storage.
0.2 µg of total RNA was used in a 20 µl RT reaction 
using AMV reverse transcriptase (Promega, Madison 
WI). 1 µl of the cDNA was used for subsequent PCR. 
The  gene-specific  primers  spanning  the  regions  of 
interest  for  cpeb1,  cpeb2,  cpeb3,  and  cpeb4  were 
designed using Vector NTI (Analysis module, Oligo 
Analysis,  Invitrogen,  Carlsbad,  CA)  and  obtained 
from IDT (Coralville, IA). Locations of these prim-
ers were demonstrated in Figure 1–4B. Sequences of 
these primers were listed in supplementary Table 9. 
PCR  was  carried  out  on  a  thermocycler  using  the 
following conditions: 95 °C 15 min for the initial 
activation; 40 cycles of: 94 °C 30 sec (denaturation), 
50–55 °C 30 sec (annealing temperature varies based 
on the primers), 72 °C 30 sec (extension); and followed 
by 72 °C 10 min (final extension). The resulting PCR 
products  were  separated  on  1%  agarose  gels  and 
photographed. Individual bands were excised, puri-
fied and sequenced to confirm their identities.
gene nomenclature
All gene symbols in the manuscript abide by the guide-
lines recommended by Human Genome Organization 
(HUGO)  Gene  Nomenclature  Committee  (HGNC), 
and are in accordance with the human HGNC database 
and the mouse genome databases (MGD). For exam-
ple, Cpeb represents mouse DNA or mRNA, Cpeb rep-
resents mouse protein, CPEB represents human DNA 
or mRNA, and CPEB represents human protein.
Data mining, sequence alignment, 
and theoretical translation
Both mouse curated RefSeq sequences (NM_) and 
uncurated cDNAs were extracted from the UniGene 
database (www.ncbi.nlm.nih.gov/unigene) to collect 
as much information as possible. For all the other 
species, only RefSeq sequences were extracted for 
simplicity.  The  genomic  sequences  were  derived 
from  UCSC  genome  database  (www.genome.ucsc.
edu).  UCSC  Blat  (www.genome.ucsc.edu/cgi-bin/
hgBlat; Genome: mouse; at default settings) was used 
to align cDNA sequences to the genome, to deduce 
the length of exons, and to define the boundaries of 
exons. The location of each alternative splice was 
determined by comparing the genomic locations of 
exon-exon boundaries. NCBI Blast was used to align 
cDNAs  to  one  another  and  to  remove  redundant 
sequences from further analysis. Whenever possible, 
partial  sequences  encompassing  alternative  regions 
of the cDNA entries were confirmed in our laboratory 
using RT-PCR and subsequent sequencing.
Mouse and human protein sequences were extrac-
ted from the UniProt database   (www.  uniprot.org/). 
The  NCBI  protein  database  (www.ncbi.nlm.nih. 
gov/  protein/)  was  also  explored  for  additional 
  information.  Mouse  protein  sequences  were  com-
pared  to  mouse  cDNA  sequences  with  the  aid  of 
computational translation using Vector NTI software 
  (Analyses module, Translation). Six frames (3 direct, 
3    complementary)  were  used  for  each  translation. 
The frame that gave the longest continuous read was 
selected, and the product designated as the protein 
product. If the translation started with the first codon 
which is not a methionine, or terminated at the last 
codon which is not a stop codon, then the cDNA is Bioinformatics analysis of Cpeb1–4
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considered “fragmented” and removed from further 
analysis. Vector NTI (Align module, AlignX—Align 
selected molecules) and ClustalW2 (www.ebi.ac.uk/
clustalw2/,  at  default  settings)  were  used  to  align 
the alternatively spliced protein isoforms as well as 
human and mouse protein orthologs.
A phylogenetic tree was generated for Cpeb1–4 from 
multiple vertebrate species with the aid of Geneious Pro 
ver 4.8 (www.geneious.com) at the following settings: 
Tree Alignment Options—Cost matrix:   Blosum62. Gap 
open penalty: 12. Gap extension penalty: 3. Alignment 
type: Global alignment with free end gaps. Tree Builder 
Options—Genetic distance model: Jukes-Cantor. Tree 
build method: Neighbor-joining. Outgroup: No Out-
group. The accession numbers of protein sequences 
used to   generate the phylogenetic tree were listed in 
  supplementary Table 10.
Functional prediction of alternatively 
used motifs
No  3D  structural  information  is  readily  available 
except  for  the  RRM  structure  for  human  CPEB3 
(NCBI Cn3D database). Whereas the deletions may 
lead  to  critical  changes  in  the  secondary/tertiary 
structures of the proteins, we could only predict the 
possible  functional  motifs  based  on  consideration 
of the linear sequences at this stage. Potential func-
tional motifs were identified with the aid of Eukary-
otic Linear Motif resource (ELM, http://elm.eu.org). 
Since the lengths of the functional motifs used by the 
ELM algorithm are within 10-aa, to keep the integ-
rity of potential motifs, we included 10-aa N-terminal 
and 10-aa C-terminal to the regions encompassing 
the short deletions. Additional predicted and experi-
mentally confirmed phosphorylation sites were from 
PhosphoSitePlus (www.phosphosite.org).
Abbreviations
Cpeb,  mouse  cytoplasmic  polyadenylation  element 
binding protein, cDNA, or used as a general term for 
the cDNA across species; Cpeb, mouse cytoplasmic 
polyadenylation  element  binding  protein,  protein, 
or used as a general term for the protein across spe-
cies;  CPEB,  human  cytoplasmic  polyadenylation 
element binding protein, cDNA; CPEB, human cyto-
plasmic  polyadenylation  element  binding  protein, 
protein; CPE, cytoplasmic polyadenylation element; 
RRM, RNA recognition motif; CDS, protein coding 
sequence;  UTR,  untranslated  region;  5’  RACE,  5’ 
rapid  amplification  of  cDNA  ends;  NMR,  nuclear 
magnetic resonance; MS, mass spectrometry; Mapk, 
mitogen-activated protein kinase; Pka, protein kinase 
a; Pkb, protein kinase b; Camk2a, calcium/calmodu-
lin-dependent protein kinase 2 alpha; Hnrnp, heteroge-
neous nuclear ribonucleoprotein; Ptbp, polypyrimidine 
tract binding protein; Pabp2, poly (A) binding protein 
2; ELM, eukaryotic linear motif.
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supplementary Materials 
Table s1. Transcript and protein variants for mouse Cpeb1. each mrnA corresponds to the protein in the same row. The 
translation is regarded as “disconnected” when none of the 6 frames gives continuous read. The translation is considered 
“fragmented” if it starts with the first codon which is not a Methionine, or terminates at the last codon which is not a stop 
codon. The asterisk * indicates that the protein sequence is not documented in any database but is derived from a theoreti-
cal translation of cDnA using Vector nTI software. cDnAs highlighted in grey are used for comparison.
mRnA size (bp) Description protein size (aa) comments
AK077799.1 1737 Mus musculus adult male  
thymus cDnA
BAc37017.1 140 (422–561) Fragmented
AK207851.1 402 Mus musculus cDnA – Disconnected 
translation
AK199617.1 379 Mus musculus cDnA – Disconnected 
translation
AK136088.1 2697 Mus musculus in vitro fertilized  
eggs cDnA product:cytoplasmic  
polyadenylation element binding  
protein 1, full insert sequence
Translated* 561 Possibly misreading 
of 1 nucleotide; 
otherwise gives 
identical product as 
nP_031781
AK135615.1 814 Mus musculus in vitro fertilized  
eggs cDnA, product:cytoplasmic  
polyadenylation element binding  
protein 1, full insert sequence
– Disconnected 
translation
Bc125476.1 1777 Mus musculus cytoplasmic  
polyadenylation element binding  
protein 1, mrnA, complete cds
AAI25477.1 562 1-aa insertion 
compared to 
nP_031781
Bc144948.1 1759 Mus musculus cDnA Translated* 556 5-aa deletion 
(PKgnM) compared 
to nP_031781
Y08260.1 2610 M.musculus mrnA for  
cPeB protein
cAA69588.1 561
nM_007755.4 2612 Mus musculus cytoplasmic  
polyadenylation element binding  
protein 1 (cpeb1), mrnA
nP_031781.1 561
Table s2. Across-paralog comparison of the exon patterns for Cpeb1. The numbers represent the lengths of exons in a 
sequential order. The locations and size of exons were determined by aligning the cDNA sequence to the genomic sequence. 
For simplicity, only one refseq sequence is used for each organism. The patterns in c. elegans and Drosophila are not 
consistent with those in the vertebrates. however the patterns among the vertebrates are highly conserved. The asterisk 
represents the variable region of ±15-nt discussed in the text, which would subsequently lead to 5-aa deletion or insertion.
c. elegans             415 360 111 91 340 216 757 nM_066650.4
Drosophila       419 500 220 482 137 232 719 181 386 1584 nM_079736.2
chicken 49 178 189 227 250 114 90 137 199 95 81 111 XM_413713.2
chimpanzee 62 1844 175 189 227 253 114 90 137 199 95 81 1504 XM_001158685.1
cow 189 189 227 253 114 90 137 199 95 81 1456 XM_864691.3
frog 91 178 201 218 253 114 105 137 199 95 81 1479 nM_001017330.2
horse 183 192 227 253 114 90 137 199 95 81 1463 XM_001498253.2
human 122 175 189 227 253 114 90 137 199 95 81 1502 nM_030594.3
marmoset 120 175 189 224 253 114 90 137 199 95 81 1469 XM_002749169.1
mouse 43 175 189 224 253 114 105 137 199 95 81 997 nM_007755.4
orangutan 256 175 189 227 253 114 90 137 199 95 81 1500 nM_001132960.1
pig 175 189 227 253 114 105 137 199 95 81 111 nM_001097510.1
rat 44 175 189 224 253 114 105 137 199 95 81 999 nM_001106276.1
zebrafish   30 169 192 209 253 114 105 137 199 95 81 1303 nM_131427.1
*Bioinformatics analysis of Cpeb1–4
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Table s3. Transcript and protein variants for mouse Cpeb2. each mrnA corresponds to the protein in the same row. The 
translation is considered “fragmented” if it starts with the first codon which is not a Methionine, or terminates at the last 
codon which is not a stop codon. The asterisk * indicates that the protein sequence is not documented in any database 
but is derived from a theoretical translation of cDnA using Vector nTI software. cDnAs highlighted in grey are used for 
comparison.
mRnA size (bp) Description protein  size 
(aa)
comments
AK076221.1 4536 Mus musculus 15 days embryo head cDnA,  Translated* 189 Fragmented
AK042065.1 2629 Mus musculus 3 days neonate thymus cDnA,  Translated* 30-aa deletion, 8-aa 
insertion compared to 
nP_787951
AB100307.1 1942 Mus musculus cpeb2 mrnA, complete cds BAc57076.1 521
nM_175937.2 1942 Mus musculus cytoplasmic polyadenylation 
element binding protein 2 (cpeb2), mrnA
nP_787951.1 521
AK164866.1 904 Mus musculus 15 days embryo head cDnA,  89 Fragmented
AK154330.1 3576 Mus musculus nOD-derived cD11c +ve 
dendritic cells cDnA, 
– Disconnected 
translation
Bc107349.1 1801 Mus musculus cytoplasmic polyadenylation 
element binding protein 2, mrnA 
AAI07350.1 521 3-nt deletion in 5’ UTR 
Bc107350.1 1801 Mus musculus cytoplasmic polyadenylation 
element binding protein 2, mrnA 
AAI07351.1 521 3-nt deletion in 5’ UTR
Table s4. Across-paralog comparison of the exon patterns for Cpeb2. The numbers represent the lengths of exons in 
a sequential order. The locations and size of exons were determined by aligning the cDNA sequence to the genomic 
sequence. For simplicity, only one refseq sequence is used for each organism. The pattern in c. elegans is not consistent 
with those in the vertebrates. however the patterns among the vertebrates are highly conserved. The asterisks represent 
the variable regions of ±90-nt and ±24-nt discussed in the text, which would subsequently lead to 30-aa and 8-aa deletion 
or insertion. The pound sign indicates a newly updated isoform in which the use of an alternative exon leads to an extra-
long protein.
c. elegans               47 337 174 236 776 196 nM_062835.2
cow     295   91 51 24 171 90 119 115 182 3994 XM_001787297.1
horse 289 91 51 24 171 90 119 115 182 3992 XM_001498900.2
human (new) 1662 282 91 51 171 90 119 115 182 4001 nM_182646.2
human 438 282 91 51 171 90 119 115 182 3998 nM_182646.1
mouse (new) 1626# 282 90 91 51 171 90 119 115 182 4006 nM_175937.3
mouse 59 200 282 90 91 51 171 90 119 115 182 472 nM_175937.2
rat 203 265 90 91 51 171 90 140 115 182 4003 nM_001108361.1
zebrafish     224   91 51   174 90 119 115 182 307 nM_001177457.1
* *Wang and cooper
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Table s5. Transcript and protein variants for mouse Cpeb3. each mrnA corresponds to the protein in the same row. The 
translation is regarded as “disconnected” when none of the 6 frames gives a continuous read. The # indicates the discrep-
ancy we found from a theoretical translation of cDnA using Vector nTI software. The asterisk * indicates that the protein 
sequence is not documented in any database but is derived from a theoretical translation of cDnA using Vector nTI soft-
ware. cDnAs highlighted in grey are used for comparison.
mRnA size (bp) Description protein size (aa) comments
AK044639.1 4223 Mus musculus adult retina cDnA Translated* 693 *189th a top codon; 
23-aa deletion
AK029261.1 2411 Mus musculus 0 day neonate  
head cDnA
Translated* 469 216-aa truncation; a 
23-aa deletion; a 8-aa 
deletion
AB093274.1 5310 Mus musculus mrnA for  
mKIAA0940 protein
BAc41458.1# 716 #reported as 722 aa, but 
we presume it is 716 aa 
identical to nP_938042, 
because the 1st 
Methionine is the 7th aa.
AY313774.1 3148 Mus musculus cytoplasmic 
polyadenylation element  
binding protein 3 (cpeb3)  
mrnA, complete cds
AAQ20843.1 716 compare to nP_938042: 
One amino acid 
conversion: 372nd n -. P
nM_198300.2 5792 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 3 (cpeb3), mrnA
nP_938042.2 716
AK147243.1 5660 Mus musculus cDnA, cytoplasmic  
polyadenylation element binding  
protein 3, full insert sequence
BAe27791.1 716
AK161513.1 2097 Mus musculus adult male testis  
cDnA, cytoplasmic  
polyadenylation element binding 
protein 3, full insert sequence
BAe36436.1 561 23-aa deletion; Early 
termination with 
conversion: VeLA -. 
geWK
Bc128377.1 2142 Mus musculus cytoplasmic 
polyadenylation element binding 
protein 3, mrnA, complete cds
AAI28378.1 477 216-aa truncation;  
a 23-aa deletion;
Bc128378.1 465 Mus musculus cDnA - Discontinued translation
Table s6. Across-paralog comparison of the exon patterns for Cpeb3. The numbers represent the lengths of exons in 
a sequential order. The locations and size of exons were determined by aligning the cDNA sequence to the genomic 
sequence. For simplicity, only one refseq sequence is used for each organism. The pattern in c. elegans is not consistent 
with those in the vertebrates. however, the patterns among the vertebrates are highly conserved. The asterisks * represent 
the variable regions of ±69-nt and ±24-nt discussed in the text, which would subsequently lead to 23-aa and 8-aa deletion 
or insertion. These two regions are alternatively spliced in several species. The # represents a predicted variable region 
of ±27-nt predicted based on the indication of variants among multiple organisms, and which may lead to a 9-aa insertion 
or deletion. The ## indicate that the first exon in human and chimpanzee (193-nt), when mapped to mouse genome, would 
locate just upstream of the first exon in mouse (61-nt). Computational translation indicates that if the 61-nt extends into and 
beyond the 193-nt, Cpeb3 protein would be continuously extended at the N-terminus. This extra-long isoform of Cpeb3, if 
proven real, would provide support for a cpeb3 isoform which is larger than 100 kD as previously reported. 
c. elegans           152 930 159 601 213 747 nM_059279.5
chimpanzee 193## 1019 160 57 141 90 119 115 182 1792 XM_001145135.1
cow 1012 160 57 141 90 119 115 182 3784 XM_875092.3
frog 1098 91 57 24 168 90 119 115 182 331 nM_001015925.2
horse 161 1010 160 57 141 90 119 115 XM_001917417.1
human 193## 1016 160 57 141 90 119 115 182 3800 nM_014912.4
mouse 61 1019 160 57 24 168 90 119 115 182 3797 nM_198300.2
rat 1209 160 57 24 168 90 119 115 182 345 XM_220043.5
zebrafish   814 85 57 24 168 90 119 115 182 252 nM_001167662.1
* * #Bioinformatics analysis of Cpeb1–4
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Table s7. Transcripts and protein variants for mouse Cpeb4. each mrnA corresponds to the protein in the same row. The 
translation is regarded as “disconnected” when none of the 6 frames gives continuous read. The translation is considered 
“fragmented” if it starts with the first codon which is not a Methionine, or terminates at the last codon which is not a stop 
codon. The asterisk * indicates that protein sequence is not documented in the database but derived from translation of 
cDnA using Vector nTI software. cDnAs highlighted in grey are used for comparison.
mRnA size (bp) Description protein size (aa) comments
AK089951.1 1774 Mus musculus kidney ccL-142  
rAg cDnA
Translated* 128 (1–128) Fragmented
AK088039.1 1904 Mus musculus 2 days neonate  
thymus thymic cells cDnA
– Disconnected 
translation
AK079421.1 3217 Mus musculus adult male  
bone cDnA,
– Disconnected 
translation
AY313775.1 2313 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 4 (cpeb4)  
mrnA, complete cds
AAQ20844.1 729
AK173229.1 7585 Mus musculus mrnA for  
mKIAA1673 protein
BAD32507.1 704 25-aa 
deletion
Bc079599.1 5437 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 4, mrnA
Translated* 339 (383–721) 8-aa deletion
AK162101.1 2164 Mus musculus in vitro  
fertilized eggs cDnA,
BAe36725.1 262 (1–262) Fragmented
AK154289.1 2438 Mus musculus nOD-derived  
cD11c +ve dendritic cells cDnA
BAe32491.1 338 (1–338) Fragmented
Bc115431.1 2279 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 4, mrnA
AAI15432.1 704 25-aa 
deletion
Bc115430.1 2279 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 4, mrnA
AAI15431.1 704 25-aa 
deletion
Bc145865.1 2300 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 4, mrnA
AAI45866.1 729
Bc145863.1 2300 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 4, mrnA
AAI45864.1 729
AK021394.1 1066 Mus musculus 0 day neonate  
eyeball cDnA
Translated* 141 (589–729) Fragmented
AK015401.1 1586 Mus musculus adult male  
testis cDnA
BAB29832.1 295 (435–729)
AK015381.1 1077 Mus musculus adult male  
testis cDnA
BAB29821.1 295 (435–729)
nM_026252.3 2312 Mus musculus cytoplasmic  
polyadenylation element  
binding protein 4 (cpeb4), mrnA
nP_080528.2 729Wang and cooper
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Table s8. Across-paralog comparison of the exon patterns for Cpeb4. The numbers represent the lengths of exons in 
a sequential order. The locations and size of exons were determined by aligning the cDNA sequence to the genomic 
sequence. For simplicity, only one refseq sequence is used for each organism. The patterns among the vertebrates are 
highly conserved. The asterisks * represent the variable regions of ±51-nt and ±24-nt discussed in the text, which would 
subsequently lead to 17-aa and 8-aa deletion or insertion. The question mark indicates that the size of the exon was 
unknown due to missing information in the genomic sequence. As a result, the alignment of the exons in grey to this map 
is uncertain.
chimpanzee 39     24 174 90 119 115 182 5091 XM_001155021.1
cow 203 82 174 90 119 115 182 4401 nM_001105420.1
dog 1682 82 51 174 90 119 115 182 4739 XM_536428.2
human 2531 82 51 24 174 90 119 115 182 4401 nM_030627.2
horse 1662 82 51 24 174 90 119 115 182 4421 XM_001502804.2
marmmoset 2541 82 51 24 174 90 119 115 182 4535 XM_002744562.1
mouse 1202 82 51 24 174 90 119 115 182 273 nM_026252.3
rabbit 1125 82 51 24 174 90 119 115 182 228 XM_002710388.1
rat 1125 82 51 174 90 119 115 182 892 nM_001106992.1
rhesus 99 82 174 90 119 115 182 4231 XM_001097641.1
zebrafish       25 1172 93 384? 115 182 375 nM_200981.1
* *
Table s9. sequences and locations of primers used for Cpeb1, Cpeb2, and Cpeb4 rT-Pcr.
Gene primer name Location sequence
Cpeb1 f 1_3 exon1/3  5′-GGCTTTCTCTCTGACTTCCAGGACTC-3′
r 3 exon 3 5′-GACTGTGTGCTGCTCTGGGCTG-3′
f 7 exon 7 5′-TGGTAAGGATGGCAAGCACCCC-3′
r 8 exon 8 5′-ACGGACTTCTCTAGTTCAAACACCAAA-3′
Cpeb2 fwd  exon 3 5′-TCAGGACAGACAACAATAGTAACACA-3′
rev  exon 8 5′-ATCTATTGGAAATAGGGAAGAGCGA-3′
Cpeb3 ex4 f 
ex5 f 
ex8 d_r1 
ex8 d_r2
exon 4 
exon 5 
exon 8(−27nt)/6 
exon 8(−27nt)/7
5′-TGGATGGAGGATAACGCTTT-3′ 
5′-CTGACCATGAGCCTCTGAAA-3′ 
5′-CATCCAAGAAGGCGTTGTTA-3′ 
5′-TCCAAGAAGGCGTCTCGTC-3′
Cpeb4 f 2_3 exon 2/3 5′-AATGATTCCATTAAAGGTCGTCTA-3′
f 2_4 exon 2/4 5′-AAATGATTCCATTAAAGCAAGG-3′
f 2_5 exon 2/5 5′-AATGATTCCATTAAAGGTCAGTCT-3′
r 5_3 exon 5/3 5′-GGAAACAATGAAGACTGACCATTA-3′
r 5_4 exon 5/4 5′-GAAACAATGAAGACTGACCTCTCC-3′
r 5 exon 5 5′-GAGGCAATCCACCCACAA-3′publish with Libertas Academica and 
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